Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies - Kauffman, HM; Cherikh, WS; Cheng, Y (Transplantation, 2005)
doi: 10.1097/01.TP.0000184006.43152.8D